胍丁胺对离体大鼠主动脉张力的影响及其受体机制

采用离体血管环灌流方法,观察了胍丁胺（agmatine,Agm)对大鼠胸主动脉张力的影响,并探讨其受体机制,实验结果如下：（1）在苯肾上腺素PE,10^-6mol/L)引起血管预收缩的 基础上,Agm(10^-7-10^-2mol/L)剂量依赖性地舒张大鼠胸主动脉。（2）上述舒张反应在去除内皮和应用NOS抑制剂N^-G-mnitro-L-arginine methyl ester(L-NAME,0.5mmol/L)后依然存在,提示Agm的舒血管作用为非内皮依赖性,并无NO的参与。（3）在高Ca^2 (3mmol/L)引起血管预收缩的基础上,Agm也可剂量依赖性地舒张大鼠主动脉。（4）预先应用α2－肾上腺素能受体（α2－adrenergic receptor,α2－AR）和咪唑啉受体（IR）阻断剂idazoxan(10^-4mol/L)则可完全阻断Agm的上述作用。（5）应用α2－AR拮抗剂yohimbine(10^-4mol/L)可部分阻断Agm对大鼠主动脉的舒张反应,以上结果表明,Agm对大鼠主动脉血管的舒张作用是由α2－AR和IR共同介导。

Action of agmatine on tension of isolated aortic artery and its receptor mechanism in rats

The effect of agmatine (Agm) on vascular tension and the underlying receptor mechanism were investigated in the isolated aortic artery of rats. The results are as follows. (1) Agm (10(-7)-10(-2) mol/L) relaxed aortic rings in a concentration-dependent manner under the condition of precontraction induced by phenylephrine (PE) at a concentration of 10(-6) mol/L. (2) Either in the intact or the endothelium-denuded rings, pretreatment with NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME, 0.5 mmol/L) did not affect the vascular relaxant action of Agm, implying that the concentration-dependent vasorelaxation caused by Agm is not endothelium-dependent and NO is not involved. (3) Agm also relaxed aortic rings in a concentration-dependent manner under the condition of precontraction induced by CaCl2 at a concentration of 3 mmol/L. (4) Idazoxan (10(-4) mol/L), an alpha 2-adrenergic receptor (alpha 2-AR) and imidazoline receptor (IR) antagonist, abolished the Agm-induced vasorelaxation completely under the condition of CaCl2-induced precontraction. (5) Yohimbine (10(-4) mol/L), a selective alpha 2-AR antagonist, could partially block the vascular relaxant action of Agm. It is suggested that the vascular relaxant effect of Agm on the rat aortic artery may be mediated by alpha 2-AR and IR.